ARTICLE | Financial News
Hatteras names Witty partner
September 19, 2017 6:21 PM UTC
Hatteras Venture Partners named Andrew Witty a venture partner on Tuesday. He retired as CEO of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) in March (see BioCentury Extra, March 17, 2016).
Witty joined GSK in 1985 and became CEO in 2008. Emma Walmsley succeeded Witty as CEO of GSK when he retired (see BioCentury Extra, Sept. 20, 2016)...